Methyltransferase-like 3 mediates m6A modification of heme oxygenase 1 mRNA to induce ferroptosis of renal tubular epithelial cells in acute kidney injury

Acute kidney injury (AKI) involves a series of syndromes characterized by a rapid increase in creatinine levels. Ferroptosis, as an iron-dependent mode of programmed cell death, reportedly participates in the pathogenesis of AKI. Methyltransferase-like 3 (METTL3)-mediated m6A modification has been recently associated with various kidney diseases; however, the mechanism of METTL3 crosstalk with the molecules involved in ferroptosis is not clearly understood. Here, we investigated the crosstalk between METTL3-mediated m6A modification and ferroptosis in AKI. METTL3-mediated m6A modification was elevated in patients with AKI, FA-AKI mice, and TBHP-stimulated TCMK-1 cells. Inhibition of METTL3 expression in vivo and in vitro alleviated the damage and ferroptosis in renal tubular cells. MeRIP sequencing showed that heme oxygenase 1 (Hmox1/HO-1) was the METTL3 target. RIP-qPCR indicated that anti-insulin-like growth factor 2 mRNA binding protein 3(IGF2BP3) could be used as a reader to bind to the methylated site of Hmox1 mRNA to maintain its stability. Hmox1 knockdown in vitro reduced the accumulation of iron ions and alleviated ferroptosis. METTL3 mediates the m6A modification of Hmox1 mRNA and maintains its stability in an IGF2BP3-dependent manner, which causes iron overload in renal tubular epithelial cells, leading to ferroptosis and AKI.